OEMINE ARTER
Food supplement declared in France, declaration No 2023-5-449
OEMINE ARTER (OEMINE) is a food supplement declared in France. Status: retrait du marché annoncé pour le 17 July 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- OEMINE
- Food business operator placing the product on the market
- PHYBIO PHARMA
- Status
- Retrait du marché annoncé pour le 17 July 2027
- Form
- Gélule
- Daily dose
- 6 gélules
- Directions for use
- 2 gélules 3 fois par jour
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Femmes enceintes
- Objectives stated by the manufacturer (these are not authorised claims)
- Artères et cholestérol
Declaration 308729, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 17 July 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Allium sativum L. | Bulbe | Extrait sec aqueux | 750 mg |
| Vitis vinifera L. | Feuille | Extrait sec aqueux | 750 mg |
| Olea europaea subsp. europaea | Feuille | Extrait sec aqueux | 600 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| Citrate de potassium | Potassium | pas de limite (données insuffisantes) | 80 mg |
Additives
E1204
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Ne pas utiliser durant la grossesse et l'allaitement ou lors de traitement anticoagulants et antihypertenseurs sans avis médical
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- OEMINE ARTER OEMINE, declared in 2024 : different composition: 0 ingredient(s) added, 1 missing
Brand : OEMINE